Some individuals with PKU can be treated with sapropterin dihydrochloride, which provides high doses of the cofactor of the phenylalanine hydroxylase enzyme, which can reduce or eliminate the need for dietary treatment [4, 8–10]. Here, PAH is linked to phenylketonuria.